All PlansCoverageHigh impact
Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions
UnitedHealthcare·Oncology, Radiation Oncology·Medical Policy
Effective date
Aug 1, 2026
We identified it
Jul 2, 2026
Summary
Unable to provide complete analysis. The policy document content was not fully provided in the source material. While the metadata indicates this is a revised medical policy effective 2026-08-01 regarding Molecular Oncology Testing for solid tumor cancer diagnosis, prognosis, and treatment decisions, the actual policy details (coverage criteria, billing codes, prior authorization requirements, and specific clinical guidelines) are not included in the analysis request. A complete policy review requires access to the full document text.
Action Required
CRITICAL: By 2026-07-31, the billing team must obtain and review the complete policy document from the source URL (https://www.uhcprovider.com/content/dam/provider/docs/public/policies/mpub-archives/commercial/medical-policy-update-bulletin-july-2026.pdf#molecular-oncology-testing-for-solid-tumor-cancer-diagnosis-prognosis-and-treatm). Once the full policy text is available, identify: (1) specific CPT/HCPCS codes for molecular oncology testing, (2) prior authorization requirements, (3) medical necessity criteria, and (4) any changes from previous policy. Update billing software, encounter forms, and provider alerts accordingly before the effective date. Failure to implement required changes may result in claim denials.